Britain’s NICE Recommends Janssen’s Stelara as New Treatment for Crohn’s Disease

Britain’s NICE Recommends Janssen’s Stelara as New Treatment for Crohn’s Disease
The United Kingdom’s National Health Service (NHS) is about to grant access to Stelara (ustekinumab) as a new treatment for Crohn’s disease, after a positive National Institute for Health and Care Excellence (NICE) recommendation is finalized. Stelara, developed and sold by Belgian pharmaceutical giant Janssen, will soon become available as a routine treatment option for adult Crohn’s patients

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *